Management Team

Our management team has extensive experience and expertise in the pharmaceutical, technical, medical and health services industries. You can view the professional bios of our management team below.


Don M. Bailey
President and Chief Executive Officer

Mr. Bailey joined Questcor in May 2007 as Interim President, and was appointed to his current position in November 2007.

Steve Cartt
Chief Operating Officer

Before joining Questcor in March 2005, Mr. Cartt worked with a variety of specialty pharma and venture capital firms to identify and pursue licensing and development opportunities, as well as to assess start-up company concepts.

Dave Medeiros
Executive Vice President & Chief Technical Officer

Dave Medeiros joined Questcor in June 2003 as Vice President, Manufacturing. Dave's experience includes management of manufacturing, inventory control, distribution, quality control, process development, and engineering functions in pharmaceutical, biotech, and medical device operating companies, and management of pharmaceutical contract manufacturers and testing laboratories.

Michael H. Mulroy
Executive Vice President, Strategic Affairs and General Counsel

Mr. Mulroy joined Questcor in January 2011. From 2003 to 2011, Mr. Mulroy was employed by the law firm of Stradling Yocca Carlson & Rauth, where he served as a partner from 2004.

Rajesh Asarpota
Senior Vice President, Chief Financial Officer and Principal Accounting Officer

Mr. Asarpota joined Questcor in February 2014 from Life Technologies Corporation, where he most recently served in a global leadership role as Vice President, Finance, responsible for providing finance leadership on the company's growth strategy, supply chain productivity, forecasting and analysis, and financial modeling for mergers and acquisitions.

David Young Pharm.D., Ph.D.
Chief Scientific Officer

Before joining Questcor in October 2009, David Young served as Executive Director & President, U.S. Operations of AGI Therapeutics plc since 2006.

Michael Aldridge
Senior Vice President, Corporate Strategic Development

Michael Aldridge joined Questcor in January 2013.  From 2010 to 2012 Mr. Aldridge was CEO of Xenome Limited, a pain focused product development company and from 2003 to 2008 he was CEO of Peplin, Inc which developed a topical treatment for skin cancer. 

Raymond Furey
Senior Vice President and Chief Compliance Officer

Ray Furey joined Questcor in October 2011. In his capacity as Vice President, Compliance & Chief Compliance Officer, he is responsible for our healthcare compliance program.

Eldon Mayer
Senior Vice President, Commercial Operations

Eldon Mayer joined Questcor in July 2008 and most recently served as a management consultant providing marketing, business and strategy expertise, as well as guidance on operational and launch plans, for a variety of biotech and pharmaceutical clients.

Ruud Helwig
General Manager, Questcor International

Ruud Helwig joined Questcor in August 2013. Mr. Helwig has extensive international experience in the healthcare industry and started his career with Eli Lilly in 1982 where he worked until 1995, with his last two  positions being Country Manager, Poland and General Manager, China.